All Infection Prevention & Control articles – Page 24
-
NewsCommon eye infection antibiotic tablet may clear up treatment-resistant sex bug
An oral antibiotic tablet used to treat common eye infections may prove an effective medicine for a sexually transmitted bug that has become resistant to usual recommended treatment.
-
NewsFDA-approved TB regimen may not work against deadliest form of TB
Investigators say their research indicates a new combination of drugs is needed to find an effective treatment for TB meningitis due to multidrug-resistant (MDR) strains.
-
NewsProtective bacterial cultures offer promise for antibiotic resistant salmonella in food
UConn researcher Dennis D’Amico and his team looked at the ability of a protective culture called Hafnia alvei B16 to prevent infection by two Salmonella serovars, a grouping within the Salmonella enterica species.
-
NewsScientists test Raman spectroscopy as diagnostic tool for Lyme disease
Two Texas A&M University scientists are developing a test for Lyme disease that’s both more accurate and more efficient than the current test.
-
NewsStudy reveals how plague spreads through wild rodent populations
Mathematical modeling reveals how fleas with early-stage Yersinia pestis infections are insufficient to drive epizootic outbreaks but can help promote a low level of enzootic plague.
-
NewsScientists identify infection-halting compound that can target hosts, not viruses
Researchers at UBC’s Life Sciences Institute have identified a compound that shows early promise at halting infections from a range of coronaviruses, including all variants of SARS-CoV-2 and the common cold.
-
NewsPotential drug takes aim at emerging Chikungunya virus
Researchers are developing what could become the first-ever treatment against the debilitating joint pain that can last months or years after becoming infected with the emerging Chikungunya virus.
-
NewsMolecules found in mucus could prevent cholera infection
MIT researchers have identified molecules found in mucus that can block cholera infection by interfering with the genes that cause the microbe to switch into a harmful state.
-
-
NewsVaccine for Lyme disease one step closer with promising six-month results
A vaccine for Lyme disease is one step closer after Pfizer Inc and Valneva SE reported positive results in their antibody persistence data six months after completing a three-dose or two-dose schdule in children and adults with vaccine candidate VLA15.
-
NewsUK PM insists penicillin isn’t running out, despite pharmacists’ warnings
Prime Minister Rishi Sunak has denied claims that Strep A antibiotics are running out, despite warnings from pharmacists.
-
NewsLiquid-coated air filter inspired by carnivorous plant can improve early capture of airborne pathogens
Researchers have designed a new liquid-coated air filter that allows for improved early detection and analysis of airborne bacteria and viruses, including the one that causes COVID-19.
-
NewsNew £1.7m containment facility will help prepare for future pandemics
A £1.7m laboratory building which will investigate infectious diseases has opened at the University of Warwick – helping to tackle some of the most globally important human diseases and prepare for pandemics of the future.
-
NewsPathogen capture method speeds up ID in children with bloodstream infections
Researchers have developed a fast and highly efficient engineered pathogen capture method which shortcuts the accurate detection of pathogens in small blood samples, potentially saving lives.
-
NewsFull ICUS and abuse of meds sparked post-pandemic outbreak of drug-resistant fungus in Brazil
Researchers in Brazil have reported the largest outbreak to date of COVID-associated candidemia caused by the same drug-resistant strain of Candida parapsilosis, a fungus that invades the bloodstream and can lead to death.
-
NewsBiovac signs deal with IVI to deliver oral cholera vaccine for African and global markets
South African based Bio-pharmaceutical company Biovac has concluded a ground-breaking licensing and technology transfer agreement with the International Vaccine Institute (IVI), a non-profit international organisation headquartered in South Korea, for the manufacture of an oral cholera vaccine (OCV).
-
NewsResearcher receives €1.5m from ERC to probe insecticide resistance in malaria transmission
Dr Victoria Ingham, a scientist at Heidelberg Medical Faculty and the German Center for Infection Research (DZIF), has been awarded an ERC Starting Grant of €1.5 million for her research on the infectious disease malaria.
-
NewsHospitals are riskier than farms when it comes to superbug transmission - but beware your pet
A deadly drug resistant bacterium that rivals MRSA is found in livestock, pets and the wider environment, but is rarely transmitted to humans through this route, scientists have found.
-
NewsFrequencies cloaked within song could trick systems into triggering deadly pathogen release
Researchers have shown how that the safe operation of a negative pressure room – a space in a hospital or biological research laboratory designed to protect outside areas from exposure to deadly pathogens – can be disrupted by an attacker armed with little more than a smartphone.
-
NewsGut parasites could aid the spread of respiratory bugs in rabbits
Researchers have found that co-infection with one or more gut parasites increases shedding of Bordetella bacterium and could increase onward transmission.
